| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | +0.0% |
| R&D Expense | $19.9M | +4.5% |
| SG&A Expense | $13.4M | +5.2% |
| Operating Income | -$33.2M | -4.8% |
| Net Income | -$32.1M | -7.6% |
| EPS (Basic) | -$0.86 | +9.5% |
| EPS (Diluted) | -$0.86 | +9.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -37.7% |
| Current Assets | $15.1M | -52.0% |
| Total Assets | $19.0M | -45.2% |
| Current Liabilities | $6.2M | -9.8% |
| Total Liabilities | $7.5M | -11.4% |
| Stockholders' Equity | $11.5M | -56.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.3M | -19.0% |
| Capital Expenditures | $1.1M | +188.2% |
| Investing Cash Flow | $12.1M | +249.3% |
| Financing Cash Flow | $9.9M | -65.3% |
| Free Cash Flow | -$26.4M | -22.0% |